Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis.
Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, Muehling J, Caan BJ, Beresford SA, Rajkovic A, Sarto GE, Marshall JR, Hammad N, Wallace RB, Makar KW, Prentice RL, Potter JD, Hayes RB, Peters U. Kocarnik JD, et al. Among authors: peters u. Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3131-9. doi: 10.1158/1055-9965.EPI-10-0878. Epub 2010 Oct 26. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20978172 Free PMC article.
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme.
Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team. Peters U, et al. Lancet. 2003 May 3;361(9368):1491-5. doi: 10.1016/S0140-6736(03)13173-X. Lancet. 2003. PMID: 12737857 Clinical Trial.
Urinary mutagenicity and colorectal adenoma risk.
Peters U, DeMarini DM, Sinha R, Brooks LR, Warren SH, Chatterjee N, Rothman N. Peters U, et al. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1253-6. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652290
Methods for etiologic and early marker investigations in the PLCO trial.
Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD; PLCO Trial Team. Hayes RB, et al. Among authors: peters u. Mutat Res. 2005 Dec 30;592(1-2):147-54. doi: 10.1016/j.mrfmmm.2005.06.013. Epub 2005 Jul 27. Mutat Res. 2005. PMID: 16054167
728 results